Name: Tissue Repair (TRP) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

TRP

Pharmaceuticals, Biotechnology & Life Sciences

Tissue Repair

Short interest: 0.01%; +0.01 pp 30d; as of 2 Dec 2025
Reported shorts: 7.7K
Shares on issue: 60.465M

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

About Tissue Repair

Tissue Repair is a clinical-stage biopharmaceutical company focused on developing advanced therapies for chronic and acute wound healing, targeting both medical and aesthetic applications. Their core technology, Glucoprime, is a yeast-derived beta-glucan with immunomodulatory effects that support tissue regeneration. The company launched TR Pro+ in June 2023 for aesthetic procedures and minor medical treatments and has initiated Phase 3 clinical trials for venous leg ulcers.

Company profile →

Tissue Repair (ASX:TRP) has 0.01% of its shares on issue reported as short positions as of 2 Dec 2025, or about 7,687 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. TRP is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Short interest

History & FAQ →

Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.

Strategy fit

How each stock picker strategy reads TRP today

Zanger BreakoutWatchScore 15rank 1517 of 1942
CAN SLIMNot a candidate
Minervini Trend TemplateWatchScore 7rank 1572 of 1716
Crowded-Short BreakoutNot a candidate
Quality compoundersNot a candidate

Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →

TRP fundamentals

In the year to 30 Jun 2026, Tissue Repair (ASX:TRP) recorded revenue of A$559.7K and a net loss after tax of A$5.4M. Net margin −958.0% (FY). Figures are in AUD, the company's reporting currency; source: Yahoo Finance, as at 14 Oct 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Full financials →